Global Bioabsorbable Stents Market to Reach USD 786.5 Million by 2033, Impelled by Growing Prevalence of Cardiovascular Diseases

December 24, 2024 | Healthcare

The latest report by IMARC Group, titled "Bioabsorbable Stents Market Report by Biomaterial (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Centers), and Region 2025-2033," finds that the global bioabsorbable stents market size reached USD 438.0 Million in 2024. Bioabsorbable stents (BRS) are advanced medical tools coated with an antiproliferative drug or gene that dissolves to restore vessel patency. It regulates the blood flow at branch points and limits the amount of blood to areas of the vascular network while also maintaining the flow. In addition, it reduces vessel irritation and inflammation, improves lesion imaging with cardiac computed tomography (CT), and facilitates repeat treatments to the same site. As a result, BRS is widely utilized in hospitals and cardiac centers across the globe.


Global Bioabsorbable Stents Market Trends:

The market is primarily driven by the growing prevalence of cardiovascular diseases caused by physical inactivity and excessive tobacco and alcohol consumption. In addition, the increasing preference for minimally invasive (MI) procedures, as they offer less postoperative pain, fewer complications, shortened hospital stay, and faster recovery times, is contributing to the market growth. Apart from this, the leading market players are conducting research and development (R&D) activities to introduce SLENDER integrated delivery system (IDS), fixed-wire, and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems to treat coronary artery disease. This, coupled with the increasing utilization of percutaneous coronary intervention (PCI) procedures for opening a blocked artery and carrying oxygen-rich blood through the body, is creating a positive market outlook across the globe. Looking forward, IMARC Group expects the market value to reach USD 786.5 Million by 2033, exhibiting a CAGR of 6.72% during the forecast period (2025-2033). 


Market Summary:

  • Based on the biomaterial, the market has been classified into polymer-based and metal-based bioabsorbable stents.
  • On the basis of the absorption rate, the market has been bifurcated into slow and fast-absorption stents.
  • Based on the application, the market has been segmented into coronary and peripheral artery disease.
  • On the basis of end user, the market has been segregated into hospitals and cardiac centers.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has been examined in the report, with some of the key players being Abbott Laboratories, Arterius Limited, B. Braun SE, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Reva Medical LLC and Terumo Corporation.

Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Biomaterial, Absorption Rate, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Arterius Limited, B. Braun SE, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Reva Medical LLC and Terumo Corporation
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Bioabsorbable Stents Market to Reach USD 786.5 Million by 2033, Impelled by Growing Prevalence of Cardiovascular Diseases
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials